, Volume 78, Issue 7, pp 759–759 | Cite as

Correction to: Apatinib: A Review in Advanced Gastric Cancer and Other Advanced Cancers

  • Lesley J. Scott

1 Correction to: Drugs

An Online First version of this article was made available online at on 16 April 2018. Errors were subsequently identified in the article, and the following corrections should be noted:
  • Rewording in main text

    Section 1, Introduction, paragraph 3, line 1: The following line, which previously read:

    “Apatinib [AiTan™ (China); Rivoceranib® (global)] is a”

    Should read:

    “Apatinib [Aitan® (brand name in China)], also known as rivoceranib, is a”

The original article has been updated.

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  1. 1.SpringerAucklandNew Zealand

Personalised recommendations